Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 66

Noname Security locks in $60m series B

The cybersecurity software provider has now secured $85m in total, having pulled in series B funding from investors including Siemens' Next47 unit.

Jul 2, 2021

Soft Robotics constructs series B extension

Tyson Foods has thrown its weight behind Harvard spinout Soft Robotics to bring the series B total to $33m.

Jul 1, 2021

Trainual studies $27m investment

4490 Ventures has reinvested in Trainual, participating in a $27m series B round a year and a half after having co-led the series A.

Jul 1, 2021

Daily Deal Round Up: June 30, 2021

SBCVC helped supply $46.5m for smart industrial software developer Ones while e-commerce marketplace aggregator 10club raised $40m in a PDC and HeyDay-backed seed round.

Jun 30, 2021

Wellthy sells Hearst on $35m series B

Existing investor Hearst backed healthcare services portal Wellthy in a series B round which pushed its overall funding to about $45m.

Jun 30, 2021

Daily Deal Round Up: June 28

Juniper Networks, Wargaming and CME Group have exited secure communications app developer Wickr in an acquisition by AWS while Country Garden reinvested in tea producer Chali.

Jun 28, 2021

Habi nets $100m in series B round

SoftBank's Latin America Fund has led the latest round for the real estate data provider, bringing its overall funding to over $115m.

Jun 28, 2021

Daily Deal Round Up: June 25, 2021

Waste management software provider Recycle Track Systems bagged $35m in a Citi-led series C round while muscular dystrophy drug developer Vita Therapeutics completed a $32m series A.

Jun 25, 2021

Daily Deal Round Up: June 24, 2021

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Jun 24, 2021

Glycomine glides to $68m series B round

Mission Bay Capital, the venture capital arm of California Institute for Quantitative Biosciences, helped the replacement therapy developer close its series B round.

Jun 24, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here